{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T20:02:54Z","timestamp":1793736174670,"version":"4.6.1"},"reference-count":72,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100016985","name":"Center for Stroke Research Berlin","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100016985","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","atherosclerosis-journal.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.atherosclerosis.2015.08.021","type":"journal-article","created":{"date-parts":[[2015,8,15]],"date-time":"2015-08-15T18:18:03Z","timestamp":1439662683000},"page":"496-503","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":179,"title":["Lipoprotein (a) as a risk factor for ischemic stroke: A meta-analysis"],"prefix":"10.1016","volume":"242","author":[{"given":"Alexander H.","family":"Nave","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin S.","family":"Lange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher O.","family":"Leonards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bob","family":"Siegerink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfram","family":"Doehner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulf","family":"Landmesser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Steinhagen-Thiessen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Endres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4260-6065","authenticated-orcid":false,"given":"Martin","family":"Ebinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.atherosclerosis.2015.08.021_bib1","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1161\/CIR.0b013e318282ab8f","article-title":"Executive summary: heart disease and stroke statistics\u20132013 update: a report from the American heart association","volume":"127","author":"Go","year":"2013","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2015.08.021_bib2","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1161\/STROKEAHA.112.663708","article-title":"Acute cerebrovascular disease in the young: the stroke in young Fabry patients study","volume":"44","author":"Rolfs","year":"2013","journal-title":"Stroke"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2015.08.021_bib3","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1161\/STROKEAHA.114.004676","article-title":"Prime time for dissecting the entity of cryptogenic stroke","volume":"45","author":"Putaala","year":"2014","journal-title":"Stroke"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2015.08.021_bib4","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1161\/01.ATV.0000144010.55563.63","article-title":"Lipoprotein(a): an elusive cardiovascular risk factor","volume":"24","author":"Berglund","year":"2004","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"4932","key":"10.1016\/j.atherosclerosis.2015.08.021_bib5","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1126\/science.2530631","article-title":"The mysteries of lipoprotein(a)","volume":"246","author":"Utermann","year":"1989","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2015.08.021_bib6","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1091\/mbc.e12-08-0637","article-title":"Apolipoprotein(a) stimulates nuclear translocation of \u03b2-catenin: a novel pathogenic mechanism for lipoprotein(a)","volume":"24","author":"Cho","year":"2013","journal-title":"Mol. Biol. Cell"},{"issue":"26","key":"10.1016\/j.atherosclerosis.2015.08.021_bib7","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1056\/NEJMoa0902604","article-title":"Genetic variants associated with Lp(a) lipoprotein level and coronary disease","volume":"361","author":"Clarke","year":"2009","journal-title":"N.\u00a0Engl. J. Med."},{"issue":"22","key":"10.1016\/j.atherosclerosis.2015.08.021_bib8","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1001\/jama.2009.801","article-title":"Genetically elevated lipoprotein(a) and increased risk of myocardial infarction","volume":"301","author":"Kamstrup","year":"2009","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.atherosclerosis.2015.08.021_bib9","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.jacc.2012.12.023","article-title":"Extreme lipoprotein(a) levels and improved cardiovascular risk prediction","volume":"61","author":"Kamstrup","year":"2013","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"issue":"24","key":"10.1016\/j.atherosclerosis.2015.08.021_bib10","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1161\/CIRCULATIONAHA.113.002432","article-title":"Lipoprotein apheresis in patients with maximally tolerated lipid-lowering therapy, lipoprotein(a)-hyperlipoproteinemia, and progressive cardiovascular disease: prospective observational multicenter study","volume":"128","author":"Leebmann","year":"2013","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2015.08.021_bib11","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/ijs.12136","article-title":"Review of lipid and lipoprotein(a) abnormalities in childhood arterial ischemic stroke","volume":"9","author":"Sultan","year":"2014","journal-title":"Int. J. Stroke"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2015.08.021_bib12","doi-asserted-by":"crossref","first-page":"802","DOI":"10.3324\/haematol.2012.073833","article-title":"Elevated lipoprotein (a), small apolipoprotein (a), and the risk of arterial ischemic stroke in North American children","volume":"98","author":"Goldenberg","year":"2013","journal-title":"Haematologica"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2015.08.021_bib13","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.1161\/ATVBAHA.112.255521","article-title":"Lipoprotein(a) and risk of coronary, cerebrovascular, and peripheral artery disease: the EPIC-Norfolk prospective population study","volume":"32","author":"Gurdasani","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"7","key":"10.1016\/j.atherosclerosis.2015.08.021_bib14","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1136\/jcp.53.7.487","article-title":"Lipoprotein (a) and stroke","volume":"53","author":"Milionis","year":"2000","journal-title":"J.\u00a0Clin. Pathol."},{"key":"10.1016\/j.atherosclerosis.2015.08.021_bib15","doi-asserted-by":"crossref","first-page":"38","DOI":"10.2174\/1874241601003020038","article-title":"Lipoprotein (a) and stroke\u202f: an overview","author":"Christogiannis","year":"2010","journal-title":"Open Clin. Chem. J."},{"issue":"4","key":"10.1016\/j.atherosclerosis.2015.08.021_bib16","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1001\/jama.2009.1063","article-title":"Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality","volume":"302","author":"Erqou","year":"2009","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2015.08.021_bib17","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1161\/STROKEAHA.106.480657","article-title":"Lipoprotein (a) and stroke: a meta-analysis of observational studies","volume":"38","author":"Smolders","year":"2007","journal-title":"Stroke"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2015.08.021_bib18","doi-asserted-by":"crossref","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"151","author":"Moher","year":"2009","journal-title":"Ann. Intern Med."},{"issue":"15","key":"10.1016\/j.atherosclerosis.2015.08.021_bib19","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","article-title":"Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group","volume":"283","author":"Stroup","year":"2000","journal-title":"JAMA"},{"issue":"7121","key":"10.1016\/j.atherosclerosis.2015.08.021_bib20","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1136\/bmj.315.7121.1533","article-title":"Meta-analysis: principles and procedures","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"10.1016\/j.atherosclerosis.2015.08.021_bib21","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d549","article-title":"Interpretation of random effects meta-analyses","volume":"342","author":"Riley","year":"2011","journal-title":"BMJ"},{"issue":"7109","key":"10.1016\/j.atherosclerosis.2015.08.021_bib22","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"10.1016\/j.atherosclerosis.2015.08.021_bib23","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1471-2288-6-50","article-title":"Development and validation of MIX: comprehensive free software for meta-analysis of causal research data","volume":"6","author":"Bax","year":"2006","journal-title":"BMC Med. Res. Methodol."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2015.08.021_bib24","first-page":"1","article-title":"Conducting meta-analyses in R with the meta for package","volume":"36","author":"Viechtbauer","year":"2010","journal-title":"J.\u00a0Stat. Softw."},{"issue":"4","key":"10.1016\/j.atherosclerosis.2015.08.021_bib25","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1161\/STROKEAHA.111.641324","article-title":"Lipid and lipoprotein biomarkers and the risk of ischemic stroke in postmenopausal women","volume":"43","author":"Berger","year":"2012","journal-title":"Stroke"},{"issue":"1\u20132","key":"10.1016\/j.atherosclerosis.2015.08.021_bib26","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jns.2009.04.002","article-title":"Risk factors for stroke and lipid-lowering effect of pravastatin on the risk of stroke in Japanese patients with hypercholesterolemia: analysis of data from the MEGA study, a large randomized controlled trial","volume":"284","author":"Uchiyama","year":"2009","journal-title":"J.\u00a0Neurol. Sci."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2015.08.021_bib27","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jns.2006.10.004","article-title":"Lipoprotein (a) and risk of ischemic stroke in young adults","volume":"252","author":"Rigal","year":"2007","journal-title":"J.\u00a0Neurol. Sci."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2015.08.021_bib28","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.atherosclerosis.2010.07.007","article-title":"Elevated serum lipoprotein(a) as a potential predictor for combined intracranial and extracranial artery stenosis in patients with ischemic stroke","volume":"212","author":"Kim","year":"2010","journal-title":"Atherosclerosis"},{"issue":"1\u20132","key":"10.1016\/j.atherosclerosis.2015.08.021_bib29","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jns.2009.02.341","article-title":"Homocysteine and lipoprotein (a) correlation in ischemic stroke patients","volume":"281","author":"Dhamija","year":"2009","journal-title":"J.\u00a0Neurol. Sci."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2015.08.021_bib30","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.atherosclerosis.2005.08.036","article-title":"Serum lipoprotein(a) levels and apolipoprotein(a) isoform size and risk for first-ever acute ischaemic nonembolic stroke in elderly individuals","volume":"187","author":"Milionis","year":"2006","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2015.08.021_bib31","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.atherosclerosissup.2012.10.004","article-title":"Factors inducing cardiovascular events in patients treated by lipoprotein apheresis","volume":"14","author":"Taseva","year":"2013","journal-title":"Atheroscler. Suppl."},{"issue":"12","key":"10.1016\/j.atherosclerosis.2015.08.021_bib32","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1161\/01.STR.0000249056.24657.8b","article-title":"Metabolic risk factors for stroke and transient ischemic attacks in middle-aged men: a community-based study with long-term follow-up","volume":"37","author":"Wiberg","year":"2006","journal-title":"Stroke"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2015.08.021_bib33","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.trsl.2007.03.005","article-title":"Thrombophilia\u2013hypofibrinolysis and atherothrombotic cardiovascular disease \u2264 age 45 years","volume":"150","author":"Glueck","year":"2007","journal-title":"Transl. Res."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2015.08.021_bib34","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.ijcard.2012.05.013","article-title":"Association between lipoprotein (a) level on admission and the incidence of subsequent cardiovascular events in patients with acute coronary syndrome","volume":"158","author":"Zhou","year":"2012","journal-title":"Int. J. Cardiol."},{"issue":"7\u20138","key":"10.1016\/j.atherosclerosis.2015.08.021_bib35","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.clinbiochem.2010.01.013","article-title":"Apo(a) phenotyping and long-term prognosis for coronary artery disease","volume":"43","author":"Ba\u00f1os-Gonz\u00e1lez","year":"2010","journal-title":"Clin. Biochem."},{"issue":"5","key":"10.1016\/j.atherosclerosis.2015.08.021_bib36","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.hlc.2009.05.001","article-title":"A\u00a0comparison of risk factors for coronary heart disease and ischaemic stroke: the Dubbo study of Australian elderly","volume":"18","author":"Simons","year":"2009","journal-title":"Hear Lung Circ."},{"key":"10.1016\/j.atherosclerosis.2015.08.021_bib37","article-title":"Pro-inflammatory interleukin-1 genotypes potentiate the risk of coronary artery disease and cardiovascular events mediated by oxidized phospholipids and lipoprotein (a)","volume":"2014","author":"Tsimikas","year":"2014","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2015.08.021_bib38","doi-asserted-by":"crossref","first-page":"e54","DOI":"10.1016\/j.thromres.2012.11.032","article-title":"Inverse association between serum lipoprotein(a) and cerebral hemorrhage in the Japanese population","volume":"131","author":"Ishikawa","year":"2013","journal-title":"Thromb. Res."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2015.08.021_bib39","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.atherosclerosis.2012.04.013","article-title":"Biomarkers and location of atherosclerosis: matrix metalloproteinase-2 may be related to intracranial atherosclerosis","volume":"223","author":"Jeon","year":"2012","journal-title":"Atherosclerosis"},{"issue":"7","key":"10.1016\/j.atherosclerosis.2015.08.021_bib40","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.jocn.2006.11.012","article-title":"Prevalence of metabolic syndrome and serum marker levels in patients with four subtypes of cerebral infarction in Japan","volume":"15","author":"Yokokawa","year":"2008","journal-title":"J.\u00a0Clin. Neurosci."},{"issue":"7","key":"10.1016\/j.atherosclerosis.2015.08.021_bib41","doi-asserted-by":"crossref","first-page":"e159","DOI":"10.1016\/j.jstrokecerebrovasdis.2012.10.013","article-title":"Lipoprotein(a), ferritin, and albumin in acute phase reaction predicts severity and mortality of acute ischemic stroke in North Indian patients","volume":"22","author":"Chakraborty","year":"2013","journal-title":"J.\u00a0Stroke Cerebrovasc. Dis."},{"issue":"4","key":"10.1016\/j.atherosclerosis.2015.08.021_bib42","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1373\/clinchem.2006.079947","article-title":"Plasma lipoprotein(a) indicates risk for 4 distinct forms of vascular disease","volume":"53","author":"Jones","year":"2007","journal-title":"Clin. Chem."},{"issue":"6","key":"10.1016\/j.atherosclerosis.2015.08.021_bib43","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1161\/01.STR.0000222666.21482.b6","article-title":"Lipoprotein(a) and incident ischemic stroke: the atherosclerosis risk in communities (ARIC) study","volume":"37","author":"Ohira","year":"2006","journal-title":"Stroke"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2015.08.021_bib44","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1097\/WNR.0000000000000094","article-title":"Prognostic value of serum lipoprotein(a) levels in patients with acute ischemic stroke","volume":"25","author":"Zhang","year":"2014","journal-title":"Neuroreport"},{"issue":"2\u20133","key":"10.1016\/j.atherosclerosis.2015.08.021_bib45","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1159\/000097640","article-title":"Lp(a) lipoprotein and plasminogen activity in patients with different etiology of ischemic stroke","volume":"23","author":"Petersen","year":"2007","journal-title":"Cerebrovasc. Dis."},{"issue":"0","key":"10.1016\/j.atherosclerosis.2015.08.021_bib46","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.cca.2013.11.029","article-title":"Serum lipoprotein(a) complexes with beta2-glycoprotein I levels in patients with ischemic stroke","volume":"429","author":"Ma","year":"2014","journal-title":"Clin. Chim. Acta"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2015.08.021_bib47","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1159\/000319065","article-title":"Increased stroke risk and lipoprotein(a) in a multiethnic community: the Northern Manhattan stroke study","volume":"30","author":"Boden-Albala","year":"2010","journal-title":"Cerebrovasc. Dis."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2015.08.021_bib48","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1007\/s10753-013-9785-x","article-title":"The relationship between serum lipoprotein (a) levels and ischemic stroke risk: a cohort study in the Chinese population","volume":"37","author":"Li","year":"2014","journal-title":"Inflammation"},{"key":"10.1016\/j.atherosclerosis.2015.08.021_bib49","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1373\/clinchem.2009.126771","article-title":"Increased plasma lipoprotein(a) found in large-artery atherosclerotic, but not small-artery occlusive, stroke","volume":"55","author":"Jones","year":"2009","journal-title":"Clin. Chem."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2015.08.021_bib50","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1161\/CIRCULATIONAHA.111.045120","article-title":"Associations between lipoprotein(a) levels and cardiovascular outcomes in black and white subjects: the atherosclerosis risk in communities (ARIC) study","volume":"125","author":"Virani","year":"2012","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2015.08.021_bib51","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1159\/000319067","article-title":"Relative contribution of lipids and apolipoproteins to incident coronary heart disease and ischemic stroke: the PRIME Study","volume":"30","author":"Canou\u00ef-Poitrine","year":"2010","journal-title":"Cerebrovasc. Dis."},{"issue":"10","key":"10.1016\/j.atherosclerosis.2015.08.021_bib52","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1161\/STROKEAHA.113.001529","article-title":"Extended-release niacin therapy and risk of ischemic stroke in patients with cardiovascular disease: the atherothrombosis intervention in metabolic syndrome with low HDL\/high triglycerides: impact on global health outcome (AIM-HIGH) trial","volume":"44","author":"Teo","year":"2013","journal-title":"Stroke"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2015.08.021_bib53","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.jstrokecerebrovasdis.2007.05.003","article-title":"Effect of aspirin on lipoprotein(a) in patients with ischemic stroke","volume":"16","author":"Ranga","year":"2007","journal-title":"J.\u00a0Stroke Cerebrovasc. Dis."},{"key":"10.1016\/j.atherosclerosis.2015.08.021_bib54","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1159\/000079200","article-title":"Relation of apolipoprotein(a) size to Alzheimer's disease and vascular dementia","volume":"18","author":"Emanuele","year":"2004","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"10.1016\/j.atherosclerosis.2015.08.021_bib55","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1161\/01.STR.0000078370.12085.02","article-title":"Pentanucleotide TTTTA repeat polymorphism of apolipoprotein(a) gene and plasma lipoprotein(a) are associated with ischemic and hemorrhagic stroke in Chinese: a multicenter case-control study in China","volume":"34","author":"Sun","year":"2003","journal-title":"Stroke"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2015.08.021_bib56","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0021-9150(99)00388-3","article-title":"Lipoprotein (a) and the risk of ischemic stroke in young women","volume":"150","author":"Wityk","year":"2000","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2015.08.021_bib57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/204748739900600101","article-title":"Lipoprotein (a) and apolipoprotein E epsilon 4 as independent risk factors for ischemic stroke","volume":"6","author":"Peng","year":"1999","journal-title":"J.\u00a0Cardiovasc Risk"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2015.08.021_bib58","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0021-9150(98)00232-9","article-title":"Apolipoprotein(a) size polymorphism in young adults with ischemic stroke","volume":"142","author":"Peynet","year":"1999","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2015.08.021_bib59","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1161\/01.STR.30.10.2013","article-title":"Chlamydia pneumoniae antibodies and high Lipoprotein(a) levels do not predict ischemic cerebral infarctions. Results from a nested case-control study in Northern Sweden","volume":"30","author":"Glader","year":"1999","journal-title":"Stroke"},{"key":"10.1016\/j.atherosclerosis.2015.08.021_bib60","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0021-9150(94)90078-7","article-title":"Relation of serum homocysteine and lipoprotein(a) concentrations to atherosclerotic disease in a prospective Finnish population based study","volume":"106","author":"Alfthan","year":"1994","journal-title":"Atherosclerosis"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2015.08.021_bib61","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jacc.2008.04.009","article-title":"Lipoprotein(a), hormone replacement therapy, and risk of future cardiovascular events","volume":"52","author":"Suk Danik","year":"2008","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"issue":"11","key":"10.1016\/j.atherosclerosis.2015.08.021_bib62","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1001\/jama.296.11.1363","article-title":"Lipoprotein(a), measured with an assay independent of apolipoprotein (a) isoform size, and risk of future cardiovascular events among initially healthy women","volume":"296","author":"Suk Danik","year":"2006","journal-title":"JAMA"},{"issue":"18","key":"10.1016\/j.atherosclerosis.2015.08.021_bib63","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1001\/jama.279.18.1477","article-title":"Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies","volume":"279","author":"Danesh","year":"1998","journal-title":"JAMA"},{"issue":"22","key":"10.1016\/j.atherosclerosis.2015.08.021_bib64","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1056\/NEJMoa001066","article-title":"Lp(a) lipoprotein, vascular disease, and mortality in the elderly","volume":"349","author":"Ariyo","year":"2003","journal-title":"N.\u00a0Engl. J. Med."},{"issue":"5","key":"10.1016\/j.atherosclerosis.2015.08.021_bib65","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1161\/01.CIR.96.5.1390","article-title":"Predictive value of electrophoretically detected lipoprotein(a) for coronary heart disease and cerebrovascular disease in a community-based cohort of 9936 men and women","volume":"96","author":"Nguyen","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2015.08.021_bib66","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1161\/01.CIR.97.10.979","article-title":"Effect of postmenopausal hormone therapy on lipoprotein(a) concentration","volume":"97","author":"Espeland","year":"1998","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2015.08.021_bib67","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0021-9150(99)00057-X","article-title":"The significance of high levels of lipoprotein (a) compared with established risk factors in premature coronary artery disease: differences between men and women","volume":"144","author":"Hahmann","year":"1999","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2015.08.021_bib68","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1161\/01.STR.25.1.74","article-title":"Lipoprotein(a) and ischemic cerebrovascular disease in young adults","volume":"25","author":"Nagayama","year":"1994","journal-title":"Stroke"},{"issue":"7","key":"10.1016\/j.atherosclerosis.2015.08.021_bib69","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1161\/01.STR.24.7.965","article-title":"High serum lipoprotein(a) levels are an independent risk factor for cerebral infarction","volume":"24","author":"Shintani","year":"1993","journal-title":"Stroke"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2015.08.021_bib70","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0021-9150(95)05743-9","article-title":"Lipoprotein(a) is an independent risk factor for multiple cerebral infarctions","volume":"122","author":"Hiraga","year":"1996","journal-title":"Atherosclerosis"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2015.08.021_bib71","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/joim.12207","article-title":"Genetic determination of lipoprotein(a) and its association with cardiovascular disease: convenient does not always mean better","volume":"276","author":"Kronenberg","year":"2014","journal-title":"J.\u00a0Intern Med."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2015.08.021_bib72","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/00041433-199906000-00005","article-title":"Lipoprotein(a): intrigues and insights","volume":"10","author":"Hobbs","year":"1999","journal-title":"Curr. Opin. Lipidol."}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915015300848?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915015300848?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,15]],"date-time":"2022-06-15T18:18:34Z","timestamp":1655317114000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915015300848"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":72,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["S0021915015300848"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2015.08.021","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lipoprotein (a) as a risk factor for ischemic stroke: A meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2015.08.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}